Menu

Exelixis, Inc. (EXEL) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript
📰

Exelixis, Inc. (EXEL) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript

All Articles on Seeking Alpha·6 days ago
#dmdQjZjO
#seekingalpha#andrew#exelixis#zanza#strategy
Reading 0:00
15s threshold

Exelixis, Inc. ( EXEL ) 3rd Annual Guggenheim Healthcare Innovation Conference November 10, 2026 9:30 AM EST

Company Participants

Andrew Peters - Senior Vice President of Strategy

Conference Call Participants

Michael Schmidt - Guggenheim Securities, LLC, Research Division

Presentation

Michael Schmidt

Guggenheim Securities, LLC, Research Division

I'm with Exelixis. With me today, I have Andrew Peters, Chief Strategy Officer. My name is Michael Schmidt, biotech analyst with Guggenheim. I'm looking really forward to this. Welcome, Andrew.

Andrew Peters

Senior Vice President of Strategy

Thank you for having me.

Question-and-Answer Session

Michael Schmidt

Guggenheim Securities, LLC, Research Division

Andrew, so Exelixis just reported solid third quarter earnings. The stock is near an all-time high. Zanza is under FDA review. How would you describe Exelixis' focus today as you bridge from cabo to the zanza franchise?

Andrew Peters

Senior Vice President of Strategy

Yes.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.